医学
白喉
免疫
类毒素
增强剂量
白喉毒素
血清流行率
免疫学
助推器(火箭)
爆发
接种疫苗
置信区间
儿科
破伤风
内科学
免疫
病毒学
免疫系统
抗体
生物
血清学
物理
毒素
生物化学
天文
作者
Noriko Kitamura,Khawater Hassan Bahkali,Elvis D Chem,Billy J Quilty,Tansy Edwards,Michiko Toizumi,Lay-Myint Yoshida
标识
DOI:10.1080/21645515.2022.2099700
摘要
Although the burden of diphtheria has declined greatly since the introduction of vaccines, sporadic outbreaks continue to be reported. WHO recommends booster doses after a primary series, but questions remain about the optimal interval between these doses. We conducted a systematic review and quantitative data analysis to quantify the duration of protective immunity after different numbers of doses. Fifteen cross-sectional seroprevalence studies provided data on geometric mean concentration (GMC). Single-year age-stratified GMCs were analyzed using a mixed-effect linear regression model with a random intercept incorporating the between-country variability. GMC was estimated to decline to 0.1 IU/ml in 2.5 years (95% CI: 0.9-4.0), 10.3 years (95% CI: 7.1-13.6), and 25.1 years (95% CI: 7.6-42.6) after receiving three, four and five doses, respectively. The results drawn from cross-sectional data collected in countries with different epidemiologies, vaccines, and schedules had several limitations. However, these analyses contribute to the discussion of optimal timing between booster doses of diphtheria toxoid-containing vaccine.
科研通智能强力驱动
Strongly Powered by AbleSci AI